Literature DB >> 2538465

A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation.

K Suzuki1, T Hayashi, J Nishioka, Y Kosaka, M Zushi, G Honda, S Yamamoto.   

Abstract

Thrombomodulin, an endothelial thrombin receptor, acts as a cofactor for the thrombin-catalyzed activation of anticoagulant protein C. The extracellular region of human thrombomodulin consists of three tentative domains, a NH2-terminal domain (D1), a domain involving six consecutive epidermal growth factor-like structures (D2), and an O-glycosylation-rich domain (D3). To identify the domain onto which thrombin binds, a series of recombinant proteins corresponding to the entire protein, D1, D2, D1 + D2, D1 + D2 + D3, and D2 + D3 were expressed in simian COS-1 cells. The proteins were partially purified by rabbit anti-thrombomodulin-F(ab')2-agarose chromatography. Western blotting analysis showed the expression of the respective recombinant proteins. All proteins involving D2, as well as D2 alone, had cofactor activity that allowed binding directly to thrombin, but D1 did not. The cofactor activity of the entire protein but not the mutants is increased in the presence of phospholipids and this is the only protein that binds to the phospholipid layer. These results indicate that the domain involving the epidermal growth factor-like structures of thrombomodulin is essential for thrombin binding and expression of the cofactor activity for protein C activation and that none of the extracellular domains interact with phospholipids.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538465

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  A case of thrombomodulin mutation causing defective thrombin binding with absence of protein C and TAFI activation.

Authors:  Masahiko Okada; Norio Tominaga; Goichi Honda; Junji Nishioka; Nobuyuki Akita; Tatsuya Hayashi; Koji Suzuki; Hiroyuki Moriuchi
Journal:  Blood Adv       Date:  2020-06-23

Review 2.  The multiple roles of epidermal growth factor repeat O-glycans in animal development.

Authors:  Amanda R Haltom; Hamed Jafar-Nejad
Journal:  Glycobiology       Date:  2015-07-14       Impact factor: 4.313

3.  Sinusoidal obstructive syndrome prophylaxis with recombinant human soluble thrombomodulin is feasible in gemtuzumab ozogamicin-treated patients undergoing allogeneic hematopoietic cell transplantation.

Authors:  S Yamamoto; R Matsuno; Y Sugishita; R Kaneko; N Okamoto; M Koganesawa; S Fujita; K Akiyama; D Toyama; K Isoyama
Journal:  Bone Marrow Transplant       Date:  2017-04-03       Impact factor: 5.483

Review 4.  Glycosaminoglycans and the regulation of blood coagulation.

Authors:  M C Bourin; U Lindahl
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

5.  The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism.

Authors:  Kazuhiro Abeyama; David M Stern; Yuji Ito; Ko-ichi Kawahara; Yasushi Yoshimoto; Motoyuki Tanaka; Tomonori Uchimura; Nobuo Ida; Yoshiaki Yamazaki; Shingo Yamada; Yasuhiko Yamamoto; Hiroshi Yamamoto; Satoshi Iino; Noboru Taniguchi; Ikuro Maruyama
Journal:  J Clin Invest       Date:  2005-04-14       Impact factor: 14.808

Review 6.  Thrombomodulin and its role in inflammation.

Authors:  Edward M Conway
Journal:  Semin Immunopathol       Date:  2011-07-31       Impact factor: 9.623

Review 7.  Novel technologies to engineer graft for tolerance induction.

Authors:  Kyle B Woodward; Feng Wang; Hong Zhao; Esma S Yolcu; Haval Shirwan
Journal:  Curr Opin Organ Transplant       Date:  2016-02       Impact factor: 2.640

Review 8.  Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin.

Authors:  Takayuki Ikezoe
Journal:  Int J Hematol       Date:  2013-11-12       Impact factor: 2.490

9.  Enhancement of thrombin-thrombomodulin-catalysed protein C activation by phosphatidylethanolamine containing unsaturated fatty acids: possible physiological significance of phosphatidylethanolamine in anticoagulant activity of thrombomodulin.

Authors:  S Horie; H Ishii; H Hara; M Kazama
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

10.  A fully active catalytic domain of bovine aspartyl (asparaginyl) beta-hydroxylase expressed in Escherichia coli: characterization and evidence for the identification of an active-site region in vertebrate alpha-ketoglutarate-dependent dioxygenases.

Authors:  S Jia; K McGinnis; W J VanDusen; C J Burke; A Kuo; P R Griffin; M K Sardana; K O Elliston; A M Stern; P A Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.